Summary: Although allergic asthma is a heterogeneous disease, allergen-specific T helper 2 (Th2) cells producing the key cytokines involved in type 2 inflammation, interleukin-4 (IL-4), IL-5 and IL-13, are thought to play a major role in asthma pathogenesis. This model is challenged by the recent discovery of group 2 innate lymphoid cells (ILC2) that represent a critical innate source of type 2 cytokines. These ILC2 are activated by epithelial cell-derived cytokines, including IL-25 and IL-33, which have been implicated in the initiation of asthma. In this review, we will discuss recent studies supporting a significant role for ILC2 in lung inflammation, with special attention to allergen-induced asthma.

, , ,
doi.org/10.1111/imm.12153, hdl.handle.net/1765/73786
Immunology: the journal of cells, molecules, system and technologies
Department of Immunology

Li, B., & Hendriks, R. (2013). Group 2 innate lymphoid cells in lung inflammation. Immunology: the journal of cells, molecules, system and technologies, 140(3), 281–287. doi:10.1111/imm.12153